Literature DB >> 2295747

Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates.

J G Webb1, Z Sasson, H Rakowski, P Liu, E D Wigle.   

Abstract

To determine the clinical course of apical hypertrophic cardiomyopathy, 26 patients (mean age 45 years) with asymmetric apical hypertrophy diagnosed by echocardiography or angiography were followed up for an average of 7.3 years (range 1 to 22). Presenting symptoms included atypical chest pain (n = 10), typical angina (n = 6), dyspnea (n = 5) and palpitation (n = 8). Ten patients were asymptomatic. At follow-up all patients had inverted precordial T waves, and 14 had the syndrome of "giant T wave negativity" (greater than or equal to 10 mm). In six patients with electrocardiographic follow-up of greater than 10 years (mean 13.4), precordial T wave inversion had progressed from -0.8 +/- 3.9 to -11.2 +/- 8.0 mm in lead V4 in association with increased QRS amplitude. Episodic atrial fibrillation occurred in 4 of 10 patients with echocardiographic left atrial enlargement. Although left ventricular systolic function was normal, diastolic relaxation was impaired in comparison with values in 10 healthy control subjects: in all 18 patients studied peak filling rate was decreased (4.44 +/- 0.44 versus 6.13 +/- 1.54 stroke volumes/s); time to peak filling was increased (174 +/- 40 versus 147 +/- 32 ms); and atrial systolic contribution to ventricular end-diastolic volume was increased (21.5 +/- 6.8 versus 11.5 +/- 4.6 stroke volume %). During follow-up, 21 of the 26 patients remained in stable condition or were asymptomatic. One patient with normal coronary arteries had an apical myocardial infarction with development of a discrete apical aneurysm and loss of "giant T wave negativity." This patient was the only one to have documented life-threatening ventricular arrhythmias.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2295747     DOI: 10.1016/0735-1097(90)90180-w

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  24 in total

Review 1.  Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy.

Authors:  E D Wigle
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

Review 2.  A potential role for integrin signaling in mechanoelectrical feedback.

Authors:  Borna E Dabiri; Hyungsuk Lee; Kevin Kit Parker
Journal:  Prog Biophys Mol Biol       Date:  2012-07-20       Impact factor: 3.667

3.  Diagnosis of apical hypertrophic cardiomyopathy using magnetic resonance imaging.

Authors:  T Ibrahim; M Schwaiger
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

4.  Apical hypertrophic cardiomyopathy: a case of slow flow in lad and malign ventricular arrhythmia.

Authors:  Emre Aksakal; Oktay Yapici; Mustafa Yazici; Ozcan Yilmaz; Mahmut Sahin
Journal:  Int J Cardiovasc Imaging       Date:  2005 Apr-Jun       Impact factor: 2.357

5.  Hypertrophic cardiomyopathy with apical aneurysm: a case of catheter and surgical therapy of sustained monomorphic ventricular tachycardia.

Authors:  M Mantica; P Della Bella; V Arena
Journal:  Heart       Date:  1997-05       Impact factor: 5.994

6.  [Cardiac arrest in a fitness trainer with apical hypertrophic cardiomyopathy associated with cor triatriatum sinister].

Authors:  E Bahlmann; H van der Schalk; A Dreher; M Schmidt-Salzmann; D Kivelitz; J Starekova; A Ghanem; K H Kuck
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-08-29       Impact factor: 0.840

7.  Resting "Solar Polar" map pattern and reduced apical flow reserve: characteristics of apical hypertrophic cardiomyopathy on SPECT myocardial perfusion imaging.

Authors:  R Parker Ward; Hemlata K Pokharna; Roberto M Lang; Kim A Williams
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

8.  Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography.

Authors:  J C C Moon; N G Fisher; W J McKenna; D J Pennell
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

9.  Myocardial perfusion SPECT in the diagnosis of apical hypertrophic cardiomyopathy.

Authors:  Tomás F Cianciulli; María C Saccheri; Osvaldo H Masoli; Marcela F Redruello; Jorge A Lax; Luis A Morita; Juan A Gagliardi; Adriana N Dorelle; Horacio A Prezioso; Luis A Vidal
Journal:  J Nucl Cardiol       Date:  2009-01-09       Impact factor: 5.952

10.  Myocardial thallium defects in apical hypertrophic cardiomyopathy are associated with a benign prognosis. Thallium defects in apical hypertrophy.

Authors:  Kyung-Han Lee; Hong-Joo Jang; Sang Chul Lee; Young-Hwan Kim; Eun-Jung Lee; Jung-Don Seo; Byung-Tae Kim
Journal:  Int J Cardiovasc Imaging       Date:  2003-10       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.